Doximity, Inc. (DOCS) Tops Q2 EPS by 2c; Guides
FREE Breaking News Alerts from StreetInsider.com!
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Needham Starts NeoVolta (NEOV) at Buy
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- SanDisk stock target lifted by Citi on continued demand strength
Doximity Announces Fiscal 2023 Second Quarter Financial Results
November 10, 2022 4:01 PM EST
Q2 total revenues of $102.2 million, up 29% year-over-year
Q2 operating cash flow of $39.5 million, up 106% year-over-year
Q2 free cash flow of $37.7 million, up 109% year-over-year
SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2023 second quarter ended September 30, 2022.
We were pleased to beat on both our top and bottom lines while delivering our first nine-figure revenue quarter, said Jeff Tangney, co-founder and CEO at Doximity. "Our... More
